Letter: Treatment of idiopathic malignant hyperthermia.
D002118:Calcium / Q000378:metabolism*; D002301:Cardiac Glycosides / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008012:Lidocaine / Q000009:adverse effects* / Q000627:therapeutic use; D008305:Malignant Hyperthermia / Q000188:drug therapy* / Q000378:metabolism; D011342:Procainamide / Q000627:therapeutic use*; D011343:Procaine / Q000627:therapeutic use*
D002301:Cardiac Glycosides; D011343:Procaine; D008012:Lidocaine; D011342:Procainamide; D002118:Calcium